{"schema_version":"secwatch.filing_event.v1","accession":"0001479681-25-000072","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2025-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.081943+00:00","generated_at":"2026-05-17T08:16:47.436469+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Nutex Health appoints Michael L. Reed as Lead Independent Director","bullets":["Michael L. Reed appointed Lead Independent Director effective Sept 2, 2025.","Reed has served on Nutex Health board since April 2022; member of Audit, Compensation, and Nominating/Governance committees.","Role includes presiding over independent director sessions and serving as liaison between board and management.","Reed will receive additional compensation per company's director compensation program as disclosed in June 2025 proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001479681-25-000072","json":"https://secwatch.observer/filing/0001479681-25-000072.json","markdown":"https://secwatch.observer/filing/0001479681-25-000072.md","text":"https://secwatch.observer/filing/0001479681-25-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000147968125000072/0001479681-25-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000147968125000072/nutx-20250904.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:16:47.436469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}